Contact
Please use this form to send email to PR contact of this press release:
Celldex Therapeutics Initiates Phase 1b Study of CDX-0159 in Chronic Spontaneous Urticaria
TO:
Please use this form to send email to PR contact of this press release:
Celldex Therapeutics Initiates Phase 1b Study of CDX-0159 in Chronic Spontaneous Urticaria
TO: